Lovastatin protects neurite degeneration in LRRK2-G2019S parkinsonism through activating the Akt/Nrf pathway and inhibiting GSK3β activity.
about
Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson diseaseMevastatin promotes neuronal survival against Aβ-induced neurotoxicity through AMPK activation.Targeted kinase inhibition relieves slowness and tremor in a Drosophila model of LRRK2 Parkinson's disease.Neuroprotective effects of statins against amyloid β-induced neurotoxicity.Modeling Parkinson's Disease in Drosophila: What Have We Learned for Dominant Traits?
P2860
Lovastatin protects neurite degeneration in LRRK2-G2019S parkinsonism through activating the Akt/Nrf pathway and inhibiting GSK3β activity.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Lovastatin protects neurite de ...... and inhibiting GSK3β activity.
@ast
Lovastatin protects neurite de ...... and inhibiting GSK3β activity.
@en
type
label
Lovastatin protects neurite de ...... and inhibiting GSK3β activity.
@ast
Lovastatin protects neurite de ...... and inhibiting GSK3β activity.
@en
prefLabel
Lovastatin protects neurite de ...... and inhibiting GSK3β activity.
@ast
Lovastatin protects neurite de ...... and inhibiting GSK3β activity.
@en
P2093
P2860
P50
P356
P1476
Lovastatin protects neurite de ...... and inhibiting GSK3β activity.
@en
P2093
Cheng-Ting Chien
Chin-Hsien Lin
Li-Ping Cao
Tzu-Ting Lai
P2860
P304
P356
10.1093/HMG/DDW068
P577
2016-02-29T00:00:00Z